Hongyuan Pharmaceutical (301246.SZ): has repurchased 0.51% of the shares accumulated.

Gelonghui December 3rd - Hongyuan Pharmaceutical (301246.SZ) announced that as of November 30, 2024, the company has repurchased a total of 2,020,200 shares of the company through a repurchase special securities account in a centralized competitive trading manner, accounting for 0.51% of the company's current total share capital. The highest fill price was 17.92 yuan/share, the lowest fill price was 12.25 yuan/share, and the total trading amount was RMB 31.4017 million yuan (excluding trading fees).

Gelonghui FinanceDec 3, 2024 16:57

Hongyuan Pharmaceuticals (301246.SZ): Sulfide electrolytes can be used in solid state batteries

Gelonghui, November 26th丨 Hongyuan Pharmaceuticals (301246.SZ) stated on the investor interaction platform that sulfide electrolytes can be used in solid state batteries, and the company currently does not have a direct business relationship with contemporary amperex technology.

Gelonghui FinanceNov 26, 2024 15:42

Express News | Hongyuan Pharmaceutical: Solid sulfide electrolytes have completed kilogram-level experiments.

BreakingsNov 18, 2024 09:12

Hongyuan Pharmaceutical: Report for the third quarter of 2024

SZSIOct 25, 2024 00:00 · Announcements

Hongyuan Pharmaceutical (301246.SZ): Supervisor Duan Xiaoliu and Lei Gaoliang's shareholding period has expired, already reduced a total of 1.1 million shares.

On September 24, Gelonhui reported that Hongyuan Pharmaceutical (301246.SZ) recently received a notice from Supervisors Mr. Duan Xiaoliu and Mr. Lei Gaoliang regarding the expiration of the shareholding reduction plan and the results of the reduction. As of September 23, 2024, the term of the shareholding reduction plan by the two individuals has expired, with a total reduction of 1.1 million shares.

Gelonghui FinanceSep 24, 2024 17:59

Hongyuan Pharmaceutical (301246.SZ) 48.0042 million shares of restricted shares will be listed for circulation on September 20th.

Announcement from Hongyuan Pharmaceutical (301246.SZ), the number of restricted shares to be lifted this time has already been issued before the company's initial public offering...

Zhitong FinanceSep 13, 2024 20:21